Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Combination of Indoleamine 2,3-Dioxygenase Expression and L-Kynurenine Level Can Identify Truly Poor Prognosis Patients with Diffuse Large B-Cell Lymphoma

Soranobu Ninomiya, MD, Nobuhiro Kanemura, MD, PhD, Hisashi Tsurumi, MD, PhD, Naoe Goto, MD, PhD, Ryoko Mabuchi, MD, Nobuhiko Nakamura, MD, Hiroshi Nakamura, MD, Senji Kasahara, MD, PhD, Takeshi Hara, MD, PhD, Tsuyoshi Takami, MD, PhD, Hisataka Moriwaki, Prof.

Blood (2011) 118 (21): 2639.

https://doi.org/10.1182/blood.V118.21.2639.2639

Published: 2011

Journal Articles

Prognositc Inpact of Tumor-Infiltrating Cells Especially CD163 Positive Macrophage in DLBCL Treated with R-CHOP

Naoe Goto, MD, PhD, Nobuhiro Kanemura, MD, PhD, Hisashi Tsurumi, MD, PhD, Nobuhiko Nakamura, MD, Senji Kasahara, MD, PhD, Takeshi Hara, MD, PhD, Hisataka Moriwaki, Tsuyoshi Takami

Blood (2011) 118 (21): 1594.

https://doi.org/10.1182/blood.V118.21.1594.1594

Published: 2011

Journal Articles

Serum Soluble Tumor Necrosis Factor Recepter 2 Levels Is Associated with the Outcome of Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP Regimen

Nobuhiko Nakamura, MD, Naoe Goto, MD, PhD, Hisashi Tsurumi, MD, PhD, Masao Takemura, PhD, Nobuhiro Kanemura, MD, PhD, Takeshi Hara, MD, PhD, Senji Kasahara, Md, PhD, Mitsuru Seishima, Tsuyoshi Takami, Hisataka Moriwaki

Blood (2011) 118 (21): 1575.

https://doi.org/10.1182/blood.V118.21.1575.1575

Published: 2011

Journal Articles

Discrepancy of CD20 Protein Expression In IHC and FCM Analyses In Primary B-Cell Lymphoma: Relationship Between FCM-Negative Phenotype and Rituximab Binding with Lymphoma Cells

Takashi Tokunaga, MD, Akihiro Tomita, MD, PhD, Kazuyuki Shimada, MD, PhD, Junji Hiraga, MD, PhD, Takumi Sugimoto, MD, PhD, Naoe Goto, MD, PhD, Tsuyoshi Takami, MD, PhD, Tomohiro Kinoshita, MD, PhD, Tomoki Naoe, MD, PhD

Blood (2010) 116 (21): 5087.

https://doi.org/10.1182/blood.V116.21.5087.5087

Published: 2010

Journal Articles

Clinical Significance of Small Intestinal Involvement Detected by Double-Balloon Enteroscopy In Patients with Non-Hodgkin's Lymphoma

Hisashi Tsurumi, MD, PhD, Takashi Ibuka, MD, Takeshi Hara, MD, PhD, Hiroshi Araki, MD, Soranobu Ninomiya, MD, Naoe Goto, MD, PhD, Humito Onogi, MD, PhD, Nobuhiro Kanemura, MD, PhD, Senji Kasahara, MD, PhD, Tomohiro Kato, MD, PhD, Tsuyoshi Takami, MD, PhD, Hisataka Moriwaki, MD, PhD

Blood (2010) 116 (21): 5075.

https://doi.org/10.1182/blood.V116.21.5075.5075

Published: 2010

Journal Articles

Clinical Impact of Endoscopic Ultrasound-Guided Fine Needle Aspiration Biopsy In the Diagnosis of Patients with Lymphoma Who Have No Superficial Lymphadenopathies

Naoe Goto, MD, PhD, Ichiro Yasuda, MD, PhD, Hisashi Tsurumi, MD, PhD, Shinpei Doi, MD, Takeshi Hara, MD, PhD, Takuji Iwashita, MD, PhD, Senji Kasahara, MD, PhD, Masanori Nakashima, MD, Nobuhiro Kanemura, MD, PhD, Seiji Adachi, MD, PhD, Takahiro Yamauchi, MD, Tsuyoshi Takami, MD, PhD, Hisataka Moriwaki, MD, PhD

Blood (2010) 116 (21): 5083.

https://doi.org/10.1182/blood.V116.21.5083.5083

Published: 2010

Journal Articles

Serum Soluble Interleukin-2 Level Determines Clinical Outcome In Patients with Follicular Lymphoma In Rituximab Era

Senji Kasahara, MD, PhD, Naoe Goto, MD, PhD, Hisashi Tsurumi, MD, PhD, Nobuhiro Nakamura, MD, Hiroshi Nakamura, MD, Nobuhiro Kanemura, MD, PhD, Takeshi Hara, MD, PhD, Tsuyoshi Takami, MD, PhD, Hisataka Moriwaki, MD, PhD

Blood (2010) 116 (21): 3106.

https://doi.org/10.1182/blood.V116.21.3106.3106

Published: 2010

Journal Articles

Serum Interleukin-18 Level Determines Clinical Outcome in Patients with Diffuse Large B-Cell Lymphoma in Rituximab Era.

Naoe Goto, Hisashi Tsurumi, MD, PhD, Senji Kasahara, Takeshi Hara, Nobuhiro Kanemura, Takeshi Yoshikawa, Soranobu Ninomiya, Kengo Ogawa, Toshiki Yamada, MD, Michio Sawada, Tsuyoshi Takami, Hisataka Moriwaki

Blood (2009) 114 (22): 1926.

https://doi.org/10.1182/blood.V114.22.1926.1926

Published: 2009

Journal Articles

The Immunohistochemical Pattern of Indoleamine 2,3-Dioxygenase in Tumor Tissue Indicates the Prognosis of Patients with Diffuse Large B-Cell Lymphoma.

Soranobu Ninomiya, Nobuhiro Kanemura, Hisashi Tsurumi, MD, PhD, Takeshi Hara, Naoe Goto, Takeshi Yoshikawa, Senji Kasahara, Masahito Shimizu, Tsuyoshi Takami, Hisataka Moriwaki

Blood (2009) 114 (22): 2924.

https://doi.org/10.1182/blood.V114.22.2924.2924

Published: 2009

Journal Articles

Serum Concentration of L-Kynurenine Can Determine Clinical Outcome of Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP

Soranobu Ninomiya, Hisashi Tsurumi, MD, PhD, Takeshi Hara, Naoe Goto, Takeshi Yoshikawa, Junichi Kitagawa, Nobuhiro Kanemura, Senji Kasahara, Tsuyoshi Takami, Hisataka Moriwaki

Blood (2008) 112 (11): 2812.

https://doi.org/10.1182/blood.V112.11.2812.2812

Published: 2008

Journal Articles

A Phase II Study of the Combination Chemotherapy Consisted of Rituximab and THP-COP Regimen as First-Line Treatment for Patients with Diffuse Large B-Cell Lymphoma

Hisashi Tsurumi, MD, PhD, Naoe Goto, Takeshi Hara, Senji Kasahara, Nobuhiro Kanemura, Junichi Kitagawa, MD, Takeshi Yoshikawa, Toshiki Yamada, Michio Sawada, Takeshi Takahashi, Tsuyoshi Takami, Hisataka Moriwaki

Blood (2008) 112 (11): 3599.

https://doi.org/10.1182/blood.V112.11.3599.3599

Published: 2008

Journal Articles

Serum Interleukin-18 Levels Are Associated with Response to Treatment and Survival in Patients with Aggressive Non-Hodgkin’s Lymphoma.

Naoe Goto, MD, Hisashi Tsurumi, MD, PhD, Masao Takemura, PhD, Takeshi Hara, MD, PhD, Michio Sawada, MD, PhD, Toshiki Yamada, MD, PhD, Senji Kasahara, MD, PhD, Nobuhiro Kanemura, MD, Takeshi Takahashi, MD, PhD, Mitsuru Seishima, MD, PhD, Tsuyoshi Takami, MD, PhD, Koshiro Saito, MD, PhD, Hisataka Moriwaki, MD, PhD

Blood (2004) 104 (11): 4543.

https://doi.org/10.1182/blood.V104.11.4543.4543

Published: 2004

Journal Articles

Fas or Fas Ligand Expression Can Determine the Clinical Outcome of Germinal Center Type in Diffuse Large B Cell Lymphoma.

Yasushi Kojima, MD, Hisashi Tsurumi, MD, PhD, Naoe Goto, MD, Michio Sawada, MD, PhD, Toshiki Yamada, MD, PhD, Takeshi Hara, MD, PhD, Takeshi Takahashi, MD, PhD, Tetsuya Yamada, MD, PhD, Masanao Saio, MD, PhD, Eiichi Tomita, MD, PhD, Tsuyoshi Takami, MD, PhD, Hisataka Moriwaki, MD, PhD

Blood (2004) 104 (11): 3267.

https://doi.org/10.1182/blood.V104.11.3267.3267

Published: 2004

Journal Articles

Serum-Soluble Tumor Necrosis Factor Receptor 2 (sTNF-R2) Level Determines Clinical Outcome in Patients with Aggressive Non-Hodgkin’s Lymphoma.

Hisashi Tsurumi, MD, PhD, Naoe Goto, MD, Masao Takemura, PhD, Takeshi Hara, MD, PhD, Michio Sawada, MD, PhD, Toshiki Yamada, MD, PhD, Senji Kasahara, MD, PhD, Nobuhiro Kanemura, MD, Takeshi Takahashi, MD, PhD, Masami Oyama, MD, PhD, Eiichi Tomita, MD, PhD, Tsuyoshi Takami, MD, PhD, Hisataka Moriwaki, MD, PhD

Blood (2004) 104 (11): 3271.

https://doi.org/10.1182/blood.V104.11.3271.3271

Published: 2004

NARROW

Combination of Indoleamine 2,3-Dioxygenase Expression and L-Kynurenine Level Can Identify Truly Poor Prognosis Patients with Diffuse Large B-Cell Lymphoma

Prognositc Inpact of Tumor-Infiltrating Cells Especially CD163 Positive Macrophage in DLBCL Treated with R-CHOP

Serum Soluble Tumor Necrosis Factor Recepter 2 Levels Is Associated with the Outcome of Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP Regimen

Discrepancy of CD20 Protein Expression In IHC and FCM Analyses In Primary B-Cell Lymphoma: Relationship Between FCM-Negative Phenotype and Rituximab Binding with Lymphoma Cells

Clinical Significance of Small Intestinal Involvement Detected by Double-Balloon Enteroscopy In Patients with Non-Hodgkin's Lymphoma

Clinical Impact of Endoscopic Ultrasound-Guided Fine Needle Aspiration Biopsy In the Diagnosis of Patients with Lymphoma Who Have No Superficial Lymphadenopathies

Serum Soluble Interleukin-2 Level Determines Clinical Outcome In Patients with Follicular Lymphoma In Rituximab Era

Serum Interleukin-18 Level Determines Clinical Outcome in Patients with Diffuse Large B-Cell Lymphoma in Rituximab Era.

The Immunohistochemical Pattern of Indoleamine 2,3-Dioxygenase in Tumor Tissue Indicates the Prognosis of Patients with Diffuse Large B-Cell Lymphoma.

Serum Concentration of L-Kynurenine Can Determine Clinical Outcome of Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP

A Phase II Study of the Combination Chemotherapy Consisted of Rituximab and THP-COP Regimen as First-Line Treatment for Patients with Diffuse Large B-Cell Lymphoma

Serum Interleukin-18 Levels Are Associated with Response to Treatment and Survival in Patients with Aggressive Non-Hodgkin’s Lymphoma.

Fas or Fas Ligand Expression Can Determine the Clinical Outcome of Germinal Center Type in Diffuse Large B Cell Lymphoma.

Serum-Soluble Tumor Necrosis Factor Receptor 2 (sTNF-R2) Level Determines Clinical Outcome in Patients with Aggressive Non-Hodgkin’s Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only